Cafepharma Today

January 17 2025 - Novo Nordisk touts 'superior' weight loss results in study of high-dose Wegovy
Novo Nordisk touts 'superior' weight loss results in study of high-dose Wegovy
AstraZeneca overhauls management of its scandal-hit China division
Lykos still plotting path to approval for rejected MDMA therapy after 'productive' FDA meeting
Ozempic tops new Medicare price negotiation list
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

ImClone says second acquirer set to bid or withdraw
Yahoo/Reuters
Monday, September 29, 2008 - 9:43am
tags:
ImClone: Second bidder has until Oct. 1 to make offer
Marketwatch
Monday, September 29, 2008 - 9:42am
tags:
Break Up To Make Up: Pfizer, Asset Sales & Layoffs
Pharmalot
Monday, September 29, 2008 - 9:40am
tags:
ImClone to Reveal Mystery Suitor?
Seeking Alpha
Monday, September 29, 2008 - 9:36am
tags:
ImClone Keeps Courting Secret Admirer
WSJ Online
Monday, September 29, 2008 - 9:04am
tags:
Predictions on Imclone's Suitors
Seeking Alpha
Monday, September 29, 2008 - 9:03am
tags:
Lilly Sinks After Hours on Effient Delay
Seeking Alpha
Monday, September 29, 2008 - 9:02am
tags:
Thallion Enrolls First Patient in TLN-4601 Phase II Trial
PR-Canada
Sunday, September 28, 2008 - 11:58am
tags:
China Biotech in Review: Deals, Developments and Financials
Seeking Alpha
Sunday, September 28, 2008 - 11:56am
tags:
Indevus: Making Big Gains with Approval for Its New Drug
Seeking Alpha
Sunday, September 28, 2008 - 11:55am
tags:
Breckenridge Pharmaceutical Signs Letter of Intent with IDL
PR-USA
Sunday, September 28, 2008 - 11:50am
tags:
Information About the Drug Spiriva Being Linked to Increased Risk of Strokes, Heart Attacks and Cardiovascular Deaths
PR Web
Sunday, September 28, 2008 - 11:49am
tags:
J&J Gets Proactive About Bad News
Forbes
Saturday, September 27, 2008 - 12:29pm
tags:
NPS shares fall as Glaxo pulls out of drug study
Yahoo/AP
Saturday, September 27, 2008 - 12:28pm
tags:
Savient shares fall as it still seeks partner
Yahoo/AP
Saturday, September 27, 2008 - 12:27pm
tags:
Lupin`s sales to grow at 17% CAGR over next 2 yrs
MyIris, India
Saturday, September 27, 2008 - 12:23pm
tags:
FDA label doesn't quash drug suit (in CA), court says
San Francisco Gate, CA
Saturday, September 27, 2008 - 12:19pm
tags:
Roche moves HC against Cipla's copycat drug
MSN News
Saturday, September 27, 2008 - 12:17pm
tags:
Keeping balance in mind at Boehringer
Danbury News Times, CT
Saturday, September 27, 2008 - 12:16pm
tags:
Zypadhera(TM) Receives Positive Opinion from the European Committee for Medicinal Products for Human Use (CHMP) for Maintenance Treatment of Schizophrenia
CNW Telbec, Canada
Saturday, September 27, 2008 - 12:15pm
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

2025 Brand Drug Challenges: A GoodRx Perspective
Drug Channels
Snake Antivenoms, Computed
In the Pipeline
Versatile Chaperones
In the Pipeline
Dealing With Being a Tumor Cell
In the Pipeline
Why 340B Reform Could Happen in 2025 (video)
Drug Channels
Drug Channels Leadership Forum: Request an Invitation Before It’s Too Late!
Drug Channels
The Pain Comes With the Territory
In the Pipeline
A New Antiviral Target, On the Host Side
In the Pipeline
Inside a Fentanyl Kitchen
In the Pipeline

Latest Jobs

Account Executive
McAlester, Oklahoma, 74502
Elara Caring
Account Executive
San Antonio, Texas, 78284
Elara Caring
Account Executive
Wichita Falls, Texas, 76309
Elara Caring
Account Executive
Dallas, Texas, 75219
Elara Caring
Account Executive, Home Health
Austin, Texas, 78703
AccentCare, Inc.
Account Executive
Monroe, Louisiana, 71201
Elara Caring
Account Executive
Clinton Township, Michigan, 48036
Elara Caring
Sales Representative- Wilmington/Harrisburg- Communications
Lancaster, Pennsylvania, 17699
Stryker
Sales Representative- Southern MD- Communications
Washington, District of Columbia, 20080
Stryker
Account Executive, Home Health
Temple, Texas, 76504
AccentCare, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information